Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502222 | SCV000594813 | uncertain significance | not specified | 2016-08-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000686436 | SCV000813954 | likely benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001549890 | SCV001770124 | likely benign | not provided | 2020-05-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367689 | SCV002659062 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-10-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001549890 | SCV005433415 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | FLNA: PP3, BS2 |
ARUP Laboratories, |
RCV001549890 | SCV005877199 | uncertain significance | not provided | 2024-10-07 | criteria provided, single submitter | clinical testing | The FLNA c.6370G>A p.Val2124Met variant (rs201396725), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 435204). This variant is found in the non-Finnish European population with an allele frequency of 0.015% (14/91,797 alleles) in the Genome Aggregation Database (v2.1.1). Computational analyses predict that this variant is deleterious (REVEL: 0.859). Due to limited information, the clinical significance of this variant is uncertain at this time. |